Iranian Journal of Basic Medical Sciences

Iranian Journal of Basic Medical Sciences

A lipid metabolism–based gene signature defines diagnosis and molecular heterogeneity in diabetic nephropathy

Articles in Press

Document Type : Original Article

Authors
Qingbu Mei 1
Xinyu Liu 2
Jing Xu 2
Shuang Li 2
Tao Wang 3
Hui Yuan 2, 4
1 School of Basic Medical Sciences, Qiqihar Medical University, Qiqihar, China
2 School of Basic Medical Sciences, Mudanjiang Medical University, Mudanjiang, China
3 Department of Anesthesiology, Mudanjiang Traditional Chinese Medicine Hospital, Mudanjiang 157011, China
4 School of Stomatology, Mudanjiang Medical University, Mudanjiang, China
10.22038/ijbms.2026.94356.20339
Abstract
Objective(s): To identify lipid metabolism-related biomarkers of diabetic nephropathy (DN), develop and validate a diagnostic model, and further explore immune infiltration patterns and molecular subtypes of DN.
Materials and Methods: Multiple public transcriptomic datasets were integrated to identify lipid metabolism-related biomarkers for DN using differential expression analysis, weighted gene co-expression network analysis, and machine learning. A diagnostic model was then constructed from these biomarkers, and its performance was evaluated using ROC curve and nomogram analyses, followed by validation in an independent cohort. In addition, immune cell infiltration was assessed with the CIBERSORT algorithm, and consensus clustering identified molecular subtypes of DN. Finally, the findings were validated in a model of type 2 diabetes.
Results: A total of 28 lipid metabolism–related differentially expressed genes were identified, and five hub biomarkers (G0S2, PTGDS, CA2, CYP27B1, and HSD17B14) were screened and demonstrated favorable diagnostic performance in both training and validation cohorts. Functional enrichment analysis revealed that these genes were mainly involved in fatty acid metabolism and PPAR signaling pathways. Immune infiltration analysis revealed significant correlations between dysregulated lipid metabolism and immune cell infiltration in DN. Consensus clustering identified distinct molecular subtypes of DN with different lipid metabolic characteristics. Critically, bioinformatic predictions were validated in db/db mice, showing significantly elevated mRNA and protein levels of all five biomarkers in DN kidneys.
Conclusion: Our findings reveal a validated lipid-metabolism-based diagnostic signature with potential for early detection, molecular stratification, and mechanistic investigation.
Keywords
Diabetic nephropathy
Immune infiltration
Lipid metabolism
Machine learning
Molecular heterogeneity
Subjects
1. Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernández C, Marchant V, Donate-Correa J, et al. Targeting inflammation to treat diabetic kidney disease: The road to 2030. Kidney Int 2023; 103: 282-296.
2. Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001; 44: 1957-1972.
3. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348.
4. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC, 3rd. From fibrosis to sclerosis: Mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-1445.
5. Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol 2019; 15: 327-345.
6. Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 2010; 19: 393-402.
7. Shen S, Ji C, Wei K. Cellular senescence and regulated cell death of tubular epithelial cells in diabetic kidney disease. Front Endocrinol (Lausanne) 2022; 13: 924299.
8. Opazo-Ríos L, Mas S, Marín-Royo G, Mezzano S, Gómez-Guerrero C, Moreno JA, et al. Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities. Int J Mol Sci 2020; 21: 2632.
9. Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 2013; 24: 1901-1912.
10. Jiang Y, Peng Y, Yang X, Yu J, Yu F, Yuan J, et al. PM(2.5) exposure aggravates kidney damage by facilitating the lipid metabolism disorder in diabetic mice. PeerJ 2023; 11: e15856.
11. Huang S, Jin Y, Zhang L, Zhou Y, Chen N, Wang W. PPAR gamma and PGC-1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF-kappaB activation. Nephrology (Carlton) 2024; 29: 858-872.
12. Wu L, Liu C, Chang DY, Zhan R, Zhao M, Man Lam S, et al. The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK/PPARα/CPT1b pathway. Diabetes 2021; 70: 2192-2203.
13. Shi J, Liu X, Jiao Y, Tian J, An J, Zou G, et al. mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets. Genes Dis 2025; 12: 101260.
14. Wang Y, Liu T, Wu Y, Wang L, Ding S, Hou B, et al. Lipid homeostasis in diabetic kidney disease. Int J Biol Sci 2024; 20: 3710-3724.
15. Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, Górriz JL, Martínez-Castelao A, Navarro-González JF. Diabetic kidney disease: From physiology to therapeutics. J Physiol 2014; 592: 3997-4012.
16. Dong B, Liu X, Yu S. Utilizing machine learning algorithms to identify biomarkers associated with diabetic nephropathy: A review. Medicine (Baltimore) 2024; 103: e37235.
17. Sun D, Wei S, Wang D, Zeng M, Mo Y, Li H, et al. Integrative analysis of potential diagnostic markers and therapeutic targets for glomerulus-associated diabetic nephropathy based on cellular senescence. Front Immunol 2023; 14: 1328757.
18. Sun Y, Dai W, He W. Identification of key immune-related genes and immune infiltration in diabetic nephropathy based on machine learning algorithms. IET Syst Biol 2023; 17: 95-106.
19. Guo C, Wang W, Dong Y, Han Y. Identification of key immune-related genes and potential therapeutic drugs in diabetic nephropathy based on machine learning algorithms. BMC Med Genomics 2024; 17: 220.
20. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.
21. Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.
22. Langfelder P, Horvath S. Fast R Functions for Robust Correlations and Hierarchical Clustering. J Stat Softw 2012; 46: i11.
23. Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc 2024; 19: 3292-3320.
24. Tay JK, Narasimhan B, Hastie T. Elastic net regularization paths for all generalized linear models. J Stat Softw 2023; 106: 1.
25. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
26. Brennan E, McEvoy C, Sadlier D, Godson C, Martin F. The genetics of diabetic nephropathy. Genes 2013; 4: 596-619.
27. Li X, Wu Y, Zhao J, Wang H, Tan J, Yang M, et al. Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus. Theranostics 2020; 10: 2675-2695.
28. Łukowicz K, Grygier B, Basta-Kaim A. Emerging role of neural stem/progenitor cell secretome in brain inflammatory response modulation. Pharmacol Rep 2025; 77: 907-920.
29. Mardones P, Chang JC, Oude Elferink RP. Cyclic AMP and alkaline pH downregulate carbonic anhydrase 2 in mouse fibroblasts. Biochim Biophys Acta 2014; 1840: 1765-1770.
30. Lidberg KA, Annalora AJ, Jozic M, Elson DJ, Wang L, Bammler TK, et al. Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease. Sci Rep 2021; 11: 4722.
31. de Bragança AC, Volpini RA, Mehrotra P, Andrade L, Basile DP. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury. Physiol Rep 2016; 4: e12829.
32. Maciejewska-Skrendo A, Cięszczyk P, Chycki J, Sawczuk M, Smółka W. Genetic markers associated with power athlete status. J Hum Kinet 2019; 68: 17-36.
33. Lei L, Yu J, Zhang B, Liu P, Meng Z, Song Y, et al. Systematic profiling reveals hepatic immune and metabolic dysregulation in DNASE1L3-deficient mice. iScience 2025; 28: 114198.
34. Poursistany H, Azar ST, Azar MT, Raeisi S. The current and emerging Klotho-enhancement strategies. Biochem Biophys Res Commun 2024; 693: 149357.
35. Hummel DM, Thiem U, Höbaus J, Mesteri I, Gober L, Stremnitzer C, et al. Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis. J Steroid Biochem Mol Biol 2013; 136: 284-288.
36. Deshpande A, Loth M, Sidiropoulos DN, Zhang S, Yuan L, Bell ATF, et al. Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces. Cell Syst 2023; 14: 285-301.
37. Heydarpour F, Sajadimajd S, Mirzarazi E, Haratipour P, Joshi T, Farzaei MH, et al. Involvement of TGF-β and autophagy pathways in pathogenesis of diabetes: A comprehensive review on biological and pharmacological insights. Front Pharmacol 2020; 11: 498758.
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 02 August 2026